D.E. Shaw & Co’s 1Life Healthcare ONEM Stock Holding History

D.E. Shaw & Co’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	-$334K	–	5168
2022 Q4	$334K	Hold	20,000	–	–	﹤0.01%	4044
2022 Q3	$343K	Hold	20,000	–	–	﹤0.01%	4241
2022 Q2	$157K	Hold	20,000	–	–	﹤0.01%	4622
2022 Q1	$222K	Hold	20,000	–	–	﹤0.01%	4815
2021 Q4	$351K	Hold	20,000	–	–	﹤0.01%	4602
2021 Q3	$405K	Buy	+20,000	New	+$514K	﹤0.01%	4203

D.E. Shaw & Co's ONEM Position: Q1 2023 in Review

D.E. Shaw & Co sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 15,797 shares — an estimated $264K sold.

D.E. Shaw & Co first reported a position in ONEM in Q1 2021 and held it in 7 quarters. The position peaked at $3.45M in Q2 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

D.E. Shaw & Co reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 15,797 1Life Healthcare shares in Q1 2023, an estimated $264K.
D.E. Shaw & Co first reported a position in 1Life Healthcare in Q1 2021 and held it in 7 quarters.
D.E. Shaw & Co's 1Life Healthcare position peaked at $3.45M in Q2 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.